BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 21534086)

  • 1. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.
    Mossman BT; Lippmann M; Hesterberg TW; Kelsey KT; Barchowsky A; Bonner JC
    J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):76-121. PubMed ID: 21534086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and chemical mechanisms of elongated mineral particle toxicities.
    Aust AE; Cook PM; Dodson RF
    J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):40-75. PubMed ID: 21534085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma.
    Case BW; Abraham JL; Meeker G; Pooley FD; Pinkerton KE
    J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):3-39. PubMed ID: 21534084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.
    Huang SX; Jaurand MC; Kamp DW; Whysner J; Hei TK
    J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):179-245. PubMed ID: 21534089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-neoplastic and neoplastic pleural endpoints following fiber exposure.
    Broaddus VC; Everitt JI; Black B; Kane AB
    J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):153-78. PubMed ID: 21534088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure.
    McConnell EE; Axten C; Hesterberg TW; Chevalier J; Miiller WC; Everitt J; Oberdörster G; Chase GR; Thevenaz P; Kotin P
    Inhal Toxicol; 1999 Sep; 11(9):785-835. PubMed ID: 10477659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological and epidemiological studies on effects of airborne fibers: coherence and public [corrected] health implications.
    Lippmann M
    Crit Rev Toxicol; 2014 Sep; 44(8):643-95. PubMed ID: 25168068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asbestos exposure indices.
    Lippmann M
    Environ Res; 1988 Jun; 46(1):86-106. PubMed ID: 3286241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short, fine and WHO asbestos fibers in the lungs of quebec workers with an asbestos-related disease.
    Adib G; Labrèche F; De Guire L; Dion C; Dufresne A
    Am J Ind Med; 2013 Sep; 56(9):1001-14. PubMed ID: 23532794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of a special-purpose glass microfiber (E glass) relative to another glass microfiber and amosite asbestos.
    Cullen RT; Searl A; Buchanan D; Davis JM; Miller BG; Jones AD
    Inhal Toxicol; 2000 Oct; 12(10):959-77. PubMed ID: 10989371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human disease consequences of fiber exposures: a review of human lung pathology and fiber burden data.
    Roggli VL
    Environ Health Perspect; 1990 Aug; 88():295-303. PubMed ID: 2272326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of asbestos-induced lung disease.
    Liu G; Cheresh P; Kamp DW
    Annu Rev Pathol; 2013 Jan; 8():161-87. PubMed ID: 23347351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation pathways for inhaled asbestos fibers.
    Miserocchi G; Sancini G; Mantegazza F; Chiappino G
    Environ Health; 2008 Jan; 7():4. PubMed ID: 18218073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases.
    Roggli VL; Sanders LL
    Ann Occup Hyg; 2000 Mar; 44(2):109-17. PubMed ID: 10717262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asbestos-related disease in the workplace and the environment: controversial issues.
    Churg A
    Monogr Pathol; 1993; (36):54-77. PubMed ID: 8107699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asbestos, asbestosis, and lung cancer: observations in Quebec chrysotile workers.
    Case BW; Dufresne A
    Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1113-9. PubMed ID: 9400709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Critique of Helsinki Criteria for Using Lung Fiber Levels to Determine Causation in Mesothelioma Cases.
    Tran T; Egilman D; Rigler M; Emory T
    Ann Glob Health; 2021; 87(1):73. PubMed ID: 34395196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of asbestos fibres in lungs of workers with asbestosis, asbestosis and lung cancer, and mesothelioma in Asbestos township.
    Dufresne A; Bégin R; Massé S; Dufresne CM; Loosereewanich P; Perrault G
    Occup Environ Med; 1996 Dec; 53(12):801-7. PubMed ID: 8994398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.